Kynam Capital Management, LP

Kynam Capital Management, LP is a private investment firm based in Princeton, New Jersey, specializing in healthcare and biotechnology investments. The firm employs a fundamental, research-driven approach, focusing on global healthcare markets and managing assets for institutional investors and high-net-worth individuals. Their investment strategy includes both long and short positions in publicly traded equities related to pharmaceutical preparations, aiming to generate alpha through deep industry knowledge and robust scientific and financial analysis.

The firm's portfolio includes significant holdings in companies such as Celldex Therapeutics Inc., Natera Inc., and Syndax Pharmaceuticals Inc. Kynam Capital Management, LP has demonstrated active engagement in the biotechnology sector, with recent transactions including increasing stakes in Vera Therapeutics Inc. and Burning Rock Biotech Ltd., as well as reducing holdings in Cogent Biosciences Inc. These actions reflect the firm's strategic approach to portfolio management and its commitment to high-growth potential stocks in the biotechnology and healthcare sectors.

Kynam Capital Management, LP was founded in 2020 and is led by Yue Tang, who serves as the Chief Compliance Officer and Managing Member. As of early 2025, the firm has approximately three employees. The firm's investment philosophy emphasizes capital protection, value investing, and alignment of interests, aiming to safeguard wealth while achieving long-term growth through investments in companies with durable competitive advantages acquired at attractive prices.